Compounds > bisindolylmaleimide iv

bisindolylmaleimide iv and arcyriaflavin a

bisindolylmaleimide iv has been researched along with arcyriaflavin a in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajakane, M; Baudet, V; Bellevergue, P; Boissin, P; Boursier, E; Coste, H; Grand-Perret, T; Loriolle, F; Pianetti, P; Toullec, D1
Buchdunger, E; Furet, P; Kump, W; Lydon, N; Mett, H; Meyer, T; Müller, M; Regenass, U; Rihs, G; Trinks, U1
Brooks, HB; Considine, E; DeHahn, TB; Dempsey, JA; Li, T; Ogg, CA; Patel, BK; Sanchez-Martinez, C; Schultz, RM; Shih, C; Spencer, CD; Watkins, SA; Zhang, F; Zhu, G1

Other Studies

3 other study(ies) available for bisindolylmaleimide iv and arcyriaflavin a

ArticleYear
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
    The Journal of biological chemistry, 1991, Aug-25, Volume: 266, Issue:24

    Topics: Adenosine Triphosphate; Alkaloids; Animals; Blood Platelets; Bombesin; Collagen; DNA; Electrophoresis, Polyacrylamide Gel; Epidermal Growth Factor; Fibroblasts; Humans; Indoles; Maleimides; Mice; Phorbol 12,13-Dibutyrate; Phosphorylation; Platelet Aggregation; Protein Kinase C; Staurosporine; Structure-Activity Relationship; Thymidine; Vimentin

1991
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase.
    Journal of medicinal chemistry, 1994, Apr-01, Volume: 37, Issue:7

    Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding, Competitive; Cells, Cultured; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Mice; Mice, Inbred BALB C; Phosphorylation; Phthalimides; Proto-Oncogene Proteins c-fos; RNA, Messenger; Structure-Activity Relationship; Tumor Cells, Cultured; Tyrosine

1994
Studies on cyclin-dependent kinase inhibitors: indolo-[2,3-a]pyrrolo[3,4-c]carbazoles versus bis-indolylmaleimides.
    Bioorganic & medicinal chemistry letters, 2003, Nov-03, Volume: 13, Issue:21

    Topics: Antineoplastic Agents; Carbazoles; Cell Division; Cell Line, Tumor; Crystallography, X-Ray; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Flow Cytometry; Humans; Molecular Conformation; Pyrroles; Structure-Activity Relationship

2003